Ameriprise’s Cardiol Therapeutics CRDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.73M Buy
+2,246,787
New +$3.58M ﹤0.01% 2728

Other funds holding CRDL

Ameriprise's CRDL Position: Q3 2026 in Review

Ameriprise opened a new position in Cardiol Therapeutics (CRDL) in Q3 2026: 2,246,787 shares worth $3.73M. The stake represents ﹤0.01% of the portfolio and ranks #2728 among its holdings.

58 funds tracked by Wall St. Rank hold CRDL as of Q3 2026.

  • Ameriprise held 2,246,787 shares of Cardiol Therapeutics worth $3.73M as of Q3 2026.
  • Cardiol Therapeutics was a new Ameriprise position in Q3 2026.
  • Cardiol Therapeutics made up ﹤0.01% of Ameriprise's portfolio in Q3 2026, its #2728 holding.
  • 58 funds tracked by Wall St. Rank held Cardiol Therapeutics as of Q3 2026.

Based on Ameriprise's 13F filing for Q3 2026, filed 16 Nov 2026.